Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Assessing the Clinical Benefits of Whole Genome Sequencing for Children With Neoplasms

NCT06820294 is registered in ClinicalTrials.gov with The Wellcome Sanger Institute as lead sponsor.

NCT NCT06820294
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06820294 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Assessing the Clinical Benefits of Whole Genome Sequencing for Children With Neoplasms
Lead sponsor
The Wellcome Sanger Institute
Phase
Observational
Overall status
Enrolling by invitation
Start date
September 22, 2022
Completion date
March 31, 2027
Enrollment
2,000 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cancer, neoplasm, pediatric cancer